The first federal product liability trial against pharmaceutical giant Merck and its arthritis painkiller Vioxx has ended in a mis-trial. The jury in Houston, Texas, was unable to decide whether Vioxx was the cause of a fatal heart attack in a man who had taken the drug for a month. The move came despite allegations in 8 December issue of the New England Journal of Medicine that some heart attack data from a …
No comments:
Post a Comment